Literature DB >> 8114698

Functional properties of a Drosophila homolog of the E2F1 gene.

K Ohtani1, J R Nevins.   

Abstract

A variety of studies have now implicated the cellular transcription factor E2F as a key participant in transcription control during the cell growth cycle. Although the recent isolation of molecular clones encoding proteins that are components of the E2F activity (E2F1 and DP-1) provides an approach to defining the specific involvement of E2F in these events, definitive experiments remain difficult in the absence of appropriate genetic systems. We have now identified a Drosophila equivalent of E2F1 that we hope will allow an eventual genetic approach to the role of E2F in cellular regulatory events. A cDNA clone was isolated from a Drosophila cDNA library by using a probe containing sequence from the E2F1 DNA binding domain. The sequence of the clone, which we term drosE2F1, demonstrates considerable homology to the human E2F1 sequence, with over 65% identity in the DNA binding region and 50% identity in the region of E2F1 known to interact with the retinoblastoma gene product. A glutathione S-transferase-drosE2F1 fusion protein was capable of binding specifically to an E2F recognition site, and transfection assays demonstrated that the drosE2F1 product was capable of transcription activation, dependent on functional E2F sites as well as sequences within the C terminus of the protein. Finally, we have also identified E2F recognition sequences within the promoter of the Drosophila DNA polymerase alpha gene, and we demonstrate that the drosE2F1 product activates transcription of a test gene under the control of this promoter. We conclude that the drosE2F1 cDNA encodes an activity with extensive structural and functional similarity to the human E2F1 protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114698      PMCID: PMC358519          DOI: 10.1128/mcb.14.3.1603-1612.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

3.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

5.  Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene.

Authors:  G R MacGregor; A E Mogg; J F Burke; C T Caskey
Journal:  Somat Cell Mol Genet       Date:  1987-05

6.  Identification of a cellular transcription factor involved in E1A trans-activation.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

7.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

View more
  44 in total

1.  E2F mediates developmental and cell cycle regulation of ORC1 in Drosophila.

Authors:  M Asano; R P Wharton
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.

Authors:  I Royzman; A J Whittaker; T L Orr-Weaver
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

3.  Novel members of the cdc2-related kinase family in Drosophila: cdk4/6, cdk5, PFTAIRE, and PITSLRE kinase.

Authors:  K Sauer; K Weigmann; S Sigrist; C F Lehner
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

4.  Characterization of dRFX2, a novel RFX family protein in Drosophila.

Authors:  Kyoko Otsuki; Yuko Hayashi; Masaki Kato; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Nucleic Acids Res       Date:  2004-10-19       Impact factor: 16.971

5.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.

Authors:  S Y Lin; A R Black; D Kostic; S Pajovic; C N Hoover; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Arabidopsis E2F1 binds a sequence present in the promoter of S-phase-regulated gene AtCDC6 and is a member of a multigene family with differential activities.

Authors:  S M de Jager; M Menges; U M Bauer; J A Murra
Journal:  Plant Mol Biol       Date:  2001-11       Impact factor: 4.076

7.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

8.  Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway.

Authors:  Dessislava K Dimova; Olivier Stevaux; Maxim V Frolov; Nicholas J Dyson
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

9.  Oncogenic capacity of the E2F1 gene.

Authors:  D G Johnson; W D Cress; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 10.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.